Background It has been suggested that serum cystatin C (cyst-C) concentration provides a better indication of changes in glomerular filtration rate (GFR) than does serum creatinine concentration.
Introduction
Assessment of glomerular ¢ltration rate (GFR) is an important tool for monitoring renal function. However, the GFR cannot be measured directly but has to be determined by measuring the clearance of a ¢ltration marker. An ideal marker should have a stable plasma concentration and should not be reabsorbed, secreted or metabolized by the kidneys. Inulin meets these requirements and for this reason has been regarded as the gold standard for measurement of GFR. Measurement of inulin clearance necessitates infusion of inulin through an indwelling catheter. 1 However, in clinical practice, determination of the GFR by inulin is quite cumbersome. Therefore, serum creatinine and creatinine clearance are widely used as non-invasive methods for the assessment of GFR. 2 Serum creatinine is the marker most commonly used for the measurement of the GFR, although several drawbacks have been identi¢ed. 3^6 Moreover, determination of creatinine clearance, which uses a 24-h urine collection, is di¤cult for patients to perform and is time-consuming and impractical for routine use. In practice, the creatinine clearance is estimated from the serum creatinine concentration.
Due to rapid developments in therapeutic interventions and preventive medicine, the demand for an accurate, fast and simple method for estimating the GFR is rapidly increasing. Cystatin C (cyst-C) meets most of these demands and appears to be an ideal endogenous marker of GFR. Several studies have suggested that serum cyst-C is a better marker of GFR than is serum creatinine, and during recent years methods have been developed for routine cyst-C measurements. The elimination of cyst-C from the circulation is almost completely due to glomerular ¢ltration. Like several other proteins with low molecular weight, cyst-C is almost completely reabsorbed and catabolized by the proximal tubules after ¢ltration, leaving a small amount of cyst-C in the urine (0¢03-0¢3 mg/L). 3,6^8 The stability of cyst-C in blood is most likely due to the natural presence of high concentrations of proteinase inhibitors and natural preservatives such as transferrin. 9 This stability makes it possible to store plasma and serum for several weeks to months before cyst-C degrades. In urine, degradation of cyst-C probably begins in the urinary tract, which makes its measurement in urine unreliable. 9 BÎkenkamp et al. 6 and Helin et al. 10 preferred cyst-C to creatinine on the basis of receiver operating curves (ROCs). However, Stickle et al. 11 showed that there were no di¡erences between cyst-C and creatinine based on ROC plots. Based on correlation coe¤cients, BÎkenkamp et al. 6 and Helin et al. 10 found cyst-C a better marker of the GFR than creatinine, whereas Stickle et al. 11 could not ¢nd any di¡erences between these markers. Newman 12 has recently stressed that cyst-C is superior to creatinine as a screening test, but there are still concerns about non-renal in£uences. Because of these contradicting results as to the usefulness of cyst-C in clinical practice, 6,10,11 we compared GFR calculated from the concentration of cyst-C with GFR derived from inulin clearance and endogenous creatinine clearance.
Patients and methods

Patients
We studied 66 patients (41 boys and 25 girls; mean age 8¢8 years, range 1¢3-21¢9 years) with several renal disorders such as re£ux nephropathy, neurogenic bladder dysfunction, renal hypoplasia, perinatal asphyxia, haemolytic uraemic syndrome and hydronephrosis. The patients visited the clinic between June 1994 and August 1999. Most of these patients had previously participated in a study involving optimization of a procedure for the determination of GFR from the clearance of inulin after a single intravenous injection. 13 Thus, the serum disappearance curves of inulin and the serum creatinine concentration measured by the Ja¡e¨method had already been determined for each patient in that study. 13 In the present study, serum samples that had been stored frozen after the ¢rst study were used for cyst-C measurement and the enzymatic determination of creatinine. The normal reference values for cyst-C are the same for adults and children. Higher values have been reported in pre-and full-term infants during the ¢rst month of life. 14 
Laboratory methods
Because of the poor accuracy of serum creatinine measurements performed by the Ja¡e¨method, determined using an Hitachi 747 (Roche, Almere, The Netherlands), creatinine was also measured by the enzymatic method on an Axon system (Bayer Diagnostics, Mijdrecht, The Netherlands). The total serum clearance of inulin after a single intravenous injection was measured as previously described. 13 Although measurement of the GFR by a continuous inulin infusion is considered the gold standard, Swinkels et al. 13 concluded that the clearance of inulin following a single injection is a suitable compromise between practical convenience and clinical accuracy for the determination of GFR in children. The serum cyst-C concentration was analysed by a fully automated particle-enhanced nephelometric method (N Latex Cystatin C Nephelometer II; Dade Behring, Marburg, Germany). 15, 16 GFR estimations based on creat-J and creat-E results were corrected to a standard body surface area of 1 ¢ 73 m 2 . The normalized GFR (A) was calculated as follows: 1¢73/Aˆ240¢8/G 0¢425 £ L 0¢725 where G is weight in kilograms and L is length in centimetres.
Statistical analysis
Comparison of the GFR inulin with the serum levels of creatinine and cyst-C were performed using the reciprocal plots of the measured concentrations, since the serum level of a substance is inversely related to its clearance. This procedure results in linearization of the curvilinear relationships between GFR and serum marker concentrations.
To determine the diagnostic value of each individual parameter, ROCs were derived. To evaluate the use of cyst-C, creat-J and creat-E for discriminating between a normal and a reduced GFR, a cut-o¡ was set arbitrarily at 80 mL/min/1¢73 m 2 . 17^19 Sensitivity and speci¢city were determined and the area under the curve (AUC) was calculated.
Results
The range (median) of the GFR, as determined by the plasma clearance of a single injection of inulin, was 7-145 mL/min/1¢73 m 2 (median 51). The serum cyst-C, creat-J and creat-E concentrations in the patient group ranged from 0¢7 to 7¢6 mg/L (median 1¢9), 38 to 871 mmol/L (median 105) and 28 to 826 mmol/L (median 126), respectively. Reciprocals of the serum concentrations of cyst-C, creat-J and creat-E correlated well with the GFR inulin (see Fig. 1 ).
The Pearson correlation coe¤cients (R) for 1/cyst-C, creat-J and creat-E were 0¢937, 0¢918 and 0¢901, respectively. These correlation coe¤cients are not statistically di¡erent from each other because of overlapping con¢dence intervals (see legend to Fig. 1 ).
Receiver operating curve plots were calculated to estimate the diagnostic accuracy of the serum parameters cyst-C, creat-J and creat-E (see Fig. 2 ). The cut-o¡ value for GFR inulin was set at 80 mL/min/1 ¢ 73 m 2 . If the optimum cut-o¡ for cyst-C and both creatinine measurements is de¢ned as the concentration at which the sum of sensitivity and speci¢city has its optimum, cyst-C would have a cut-o¡ level of 1¢1mg/L with a sensitivity of 97% and a speci¢city of 89%. Creat-J would have a cut-o¡ level of 78 mmol/L with a sensitivity of 86% and a speci¢city of100%. For creat-E this would be 71 mmol/ L with a sensitivity of 95% and a speci¢city of 89%. The diagnostic accuracy of the parameters is similar because of overlapping con¢dence intervals (see legend of Fig. 2 ).
Discussion
In this study, cyst-C, creat-J and creat-E were measured in parallel with GFR inulin in a population of paediatric patients with renal disorders and the characteristics of the relationship of cyst-C and both creatinines with GFR inulin were compared.
There was a close association between 1/cyst-C and GFR inulin , and the correlation coe¤cients between 1/creat-J and GFR inulin and between 1/creat-E and GFR inulin were similar. The correlation coe¤cients found in this study are higher than those found in previous studies. 6, 10, 11 The study of Stickle et al. 11 , in a comparable patient population, showed similar correlation coe¤cients with GFR of cyst-C, Rˆ0 ¢77 (4-12 years) and Rˆ0 ¢87 (12-19 years) in comparison with creatinine, and Rˆ0 ¢84 (4-12 years) and Rˆ0 ¢89 (12-19 years) in comparison with inulin, which is in accordance with our results. BÎkenkamp et al. 6 and Helin et al. 10 found better correlation coe¤cients for 1/cyst-C: Rˆ0 ¢88 and Rˆ0 ¢83, respectively (for 1/creatinine these were Rˆ0 ¢72 and Rˆ0 ¢67, respectively). The GFR was measured with continuous infusion of inulin and with Cr-EDTA, respectively. The patient groups in the studies of BÎkenkamp et al. 6 and Helin 13 were somewhat similar except that there were more children studied after renal and liver transplantation (46%) in the BÎkenkamp study. Risch et al. 20 demonstrated that transplant patients receiving glucocorticoid medication have higher cyst-C concentrations than comparable groups with glucocorticoidfree immunosuppression.
The con¢dence intervals of the area under the curve (AUC) in the ROC of cyst-C and both creatinine measurements overlap, which indicates that the diagnostic accuracy of these parameters is not signi¢cantly di¡erent. Both BÎkenkamp et al. 6 and Helin et al. 10 found in their study that creatinine, from a diagnostic point of view, is inferior to cyst-C because of a greater AUC for cyst-C.
The optimum ROC point (where the sum of sensitivity and speci¢city is maximal) for cyst-C provided a cut-o¡ concentration of 1¢1mg/ L. The ROC analysis of Stickle et al. 11 is in agreement with our results. They found cut-o¡ concentrations of 1¢2 mg/ L (4-12 years) and 1¢4 mg/L (12-19 years) with a sensitivity of 80% and 87%, respectively, and a speci¢city of 91% and 100%, respectively (cut-o¡ value for GFR inulin was 90 mL/min/1 ¢ 73 m 2 ).
In conclusion, serum cyst-C has the advantages of not being in£uenced by height, age (in the population of this study) or gender, and the assay is not subject to any analytical interferences. However, the diagnostic accuracy of cyst-C does not appear to be superior to that of either creatinine measurement in the paediatric population investigated. The results from this study, together with the higher costs and longer assay time of cyst-C compared with those of creatinine, lead us to suggest that use of cyst-C as a marker of the GFR is of no advantage in paediatric populations. Figure 2 . Non-parametric receiver operating curves for the diagnostic accuracy of serum concentrations of cystatin C (cyst-C), creatinine measured by the Jaffé reaction (creat-J) and creatinine measured by the enzymatic method (creat-E) in distinguishing between a normal and a reduced glomerular ltration rate. (a) Cyst-C: AUCˆ0¢967 (95% CI: 0¢910-1¢000). (b) Creat-J: AUCˆ0¢977 (95% CI: 0¢948-1¢000). (c) Creat-E: AUCˆ0¢924 (95% CI: 0¢820-1¢000). AUCˆarea under the curve; 95% CIˆ95% con dence interval.
